<< Read Full Article
<< Read Full Article
Updated from 9:16 a.m. EDT
Change in Ratings
Amylin Pharmaceuticals (AMLN Quote) upgraded at Merrill to Buy. $27 price target. Stock is down 25% on the latest Byetta news and looks attractive for a trade.
Energen (EGN Quote) upgraded at UBS to Buy from Neutral. Maintains 2008 EPS estimates of $4.58 and $80 price target. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,328.89 | 1,102.47 | 2,211.69 | 35.46 |
Oil *
73.88
|
|
UP
20.63
|
UP
6.40
|
UP
31.64
|
UP
0.59
|
10 Yr
3.55%
SPDR Gold
108.95
|
|
+0.20%
|
+0.58%
|
+1.45%
|
+1.69%
|
Data delayed 20 minutes |
Connect with TheStreet